NYSE - Delayed Quote • USD
Concord Medical Services Holdings Limited (CCM)
At close: 3:26 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
537,402.0000
537,402.0000
472,085.0000
485,633.0000
223,011.0000
Cost of Revenue
614,010.0000
614,010.0000
624,494.0000
542,530.0000
209,928.0000
Gross Profit
-76,608.0000
-76,608.0000
-152,409.0000
-56,897.0000
13,083.0000
Operating Expense
386,377.0000
386,377.0000
372,639.0000
401,421.0000
320,584.0000
Operating Income
-462,985.0000
-462,985.0000
-525,048.0000
-458,318.0000
-307,501.0000
Net Non Operating Interest Income Expense
-154,837.0000
-154,837.0000
-110,336.0000
-67,895.0000
-72,919.0000
Other Income Expense
62,228.0000
62,228.0000
-204,512.0000
-3,024.0000
-61,233.0000
Pretax Income
-555,594.0000
-555,594.0000
-839,896.0000
-529,237.0000
-441,653.0000
Tax Provision
-24,573.0000
-24,573.0000
-70,906.0000
-6,565.0000
-37,624.0000
Net Income Common Stockholders
-297,658.0000
-297,658.0000
-489,661.0000
-820,621.0000
-669,906.0000
Diluted NI Available to Com Stockholders
-297,658.0000
-297,658.0000
-489,661.0000
-820,621.0000
-669,906.0000
Basic EPS
-10.68
-6.81
-11.22
-18.78
-15.33
Diluted EPS
-10.68
-6.81
-11.22
-18.78
-15.33
Basic Average Shares
43,684.6190
43,684.6190
43,684.6190
43,684.6190
43,684.6190
Diluted Average Shares
43,684.6190
43,684.6190
43,684.6190
43,684.6190
43,684.6190
Total Operating Income as Reported
-462,985.0000
-462,985.0000
-525,048.0000
-458,318.0000
-316,001.0000
Total Expenses
1,000,387.0000
1,000,387.0000
997,133.0000
943,951.0000
530,512.0000
Net Income from Continuing & Discontinued Operation
-297,658.0000
-297,658.0000
-489,661.0000
-271,427.0000
-309,989.0000
Normalized Income
-347,623.8309
-347,623.8309
-484,577.7129
-251,710.6464
-242,690.0177
Interest Income
10,832.0000
10,832.0000
10,021.0000
5,894.0000
8,440.0000
Interest Expense
165,669.0000
165,669.0000
120,357.0000
73,789.0000
81,359.0000
Net Interest Income
-154,837.0000
-154,837.0000
-110,336.0000
-67,895.0000
-72,919.0000
EBIT
-389,925.0000
-389,925.0000
-719,539.0000
-455,448.0000
-360,294.0000
EBITDA
-261,471.0000
-261,471.0000
-586,725.0000
-351,368.0000
-279,995.0000
Reconciled Cost of Revenue
614,010.0000
614,010.0000
624,494.0000
542,530.0000
209,928.0000
Reconciled Depreciation
128,454.0000
128,454.0000
132,814.0000
104,080.0000
80,299.0000
Net Income from Continuing Operation Net Minority Interest
-297,658.0000
-297,658.0000
-489,661.0000
-271,427.0000
-309,989.0000
Total Unusual Items Excluding Goodwill
52,278.0000
52,278.0000
-5,552.0000
-19,964.0000
-73,566.0000
Total Unusual Items
52,278.0000
52,278.0000
-5,552.0000
-19,964.0000
-73,566.0000
Normalized EBITDA
-313,749.0000
-313,749.0000
-581,173.0000
-331,404.0000
-206,429.0000
Tax Rate for Calcs
0.0000
0.0000
0.0001
0.0000
0.0001
Tax Effect of Unusual Items
2,312.1691
2,312.1691
-468.7129
-247.6464
-6,267.0177
12/31/2020 - 12/11/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade